Thompson v. Abbott Laboratories, Inc. et al

Thirteen motions hit the docket on a single day. On April 20, 2026, the court entered a wave of orders in Thompson v. Abbott Laboratories, Inc.

et al, docket 23-cv-05129, including a ruling on a motion to withdraw as attorney. That volume of activity on one date, in a case that has been running since 2023, points to a pressure point — not routine housekeeping.

The underlying suit names Abbott Laboratories and additional defendants. Abbott is one of the largest pharmaceutical and medical device companies in the country.

Cases filed against Abbott in this posture typically involve product liability or personal injury claims tied to a drug or device, though the available docket does not confirm the theory of liability here. The co-defendants are not identified in current records.

No judge is listed for this case. That gap is not trivial. Without a named judge, there is no way to read how the court is likely to handle the withdrawal, what scheduling deadlines are in play, or whether any dispositive motions are pending.

The court of record is also unconfirmed.

The attorney withdrawal is the event to watch. Counsel exits mid-litigation for a short list of reasons: a fee dispute, a breakdown with the client, or a strategic decision that the case no longer makes economic sense to carry.

If Thompson is an individual plaintiff now left without representation, the court will typically set a deadline to retain new counsel. Miss that deadline and the case risks dismissal for failure to prosecute — a result Abbott's defense team would welcome.

The cluster of thirteen orders on April 20 suggests the court or the parties moved fast to address the fallout. Whether those orders include a stay, a new scheduling order, or something more adverse to the plaintiff is not yet visible in available records. Abbott has every incentive to press any advantage while plaintiff's counsel situation is unsettled.